Postpartum thromboembolism: Severe events might be preventable using a new risk score model

Vascular Health and Risk Management

Volumn 4, Issue 5, 2008, Pages 1081-1087

  Lindqvist, Pelle G ^a,b   Torsson, Jelena ^a   Almqvist, Åsa ^a   Björgell, Ola ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Health care financing; Low molecular weight heparin; Phlebography; Scoring system; Thromboprophylaxis; Ultrasonography

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANAMNESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEALTH CARE SYSTEM; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LUNG EMBOLISM; PUERPERIUM; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS PREVENTION; UNSPECIFIED SIDE EFFECT; VENOUS THROMBOEMBOLISM;

ADULT; ALGORITHMS; COST-BENEFIT ANALYSIS; DRUG COSTS; FEMALE; FIBRINOLYTIC AGENTS; HEALTH STATUS INDICATORS; HOSPITAL COSTS; HUMANS; PATIENT SELECTION; POSTPARTUM PERIOD; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PREGNANCY; PUERPERAL DISORDERS; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SWEDEN; THROMBOEMBOLISM; TIME FACTORS; VENOUS THROMBOSIS;

EID: 56849111156     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Drife J. 2003. Thromboembolism. Br Med Bull, 67:177-90.
2. Drife J. 2004. Why mothers die, 2000 to 2002 report. Confidential enquiries into maternal deaths [online]. Accessed on June 10, 2008. URL: http://www.cemach.org.uk/Publications/ Saving-Mothers-Lives-Report-2000-2002.aspx.
3. Friederich PW, Sanson BJ, Simioni P, et al. 1996. Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis. Ann Intern Med, 125:955-60.
4. Juul K, Tybjaerg-Hansen A, Schnohr P, et al. 2004. Factor V Leiden and the risk for venous thromboembolism in the adult Danish population. Ann Intern Med, 140:330-7.
5. Kahn SR, Hirsch A, Shrier I. 2002. Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med, 162:1144-8.
6. Lindqvist P, Dahlbäck B, Marsál K. 1999. Thrombotic risk during pregnancy: a population study. Obstet Gynecol, 94:595-9.
7. Lindqvist PG, Dahlbäck B. 2000. Bleeding complications associated with low molecular weight heparin prophylaxis during pregnancy. Thromb Haemost, 84:140-1.
8. Lindqvist PG, Hellgren M, Nord E, et al. 2006. Thrombosis prophylaxis decisions in pregnancy - simpler with risk scores. Läkartidningen, 103:1429-32.
9. Lindqvist PG, Kublikas M, Dahlbäck B. 2002a. Individual risk assessment of thrombosis in pregnancy. Acta Obstet Gynecol Scand, 81:412-16.
10. Lindqvist PG, Olofsson P, Dahlbäck B. 2002b. Use of selective factor V Leiden screening in pregnancy to identify candidates for anticoagulants. Obstet Gynecol, 100:332-6.
11. Lindqvist PG, Svensson PJ, Marsál K, et al. 1999. Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost, 81:532-7.
12. Martinelli I, Legnani C, Bucciarelli P, et al. 2001. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost, 86:800-3.
13. Mismetti P, Laporte S, Darmon JY, et al. 2001. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg, 88:913-30.
14. Preston FE, Rosendaal FR, Walker ID, et al. 1996. Increased fetal loss in women with heritable thrombophilia. Lancet, 348:913-6.
15. Prochazka M, Happach C, Marsal K, et al. 2003. Factor V Leiden in pregnancies complicated by placental abruption. BJOG, 110:462-6.
16. Prochazka M, Lubusky M, Slavik L, et al. 2007. Frequency of selected thrombophilias in women with placental abruption. Aust N Z J Obstet Gynaecol, 47:297-301.
17. Salonen Ros H, Lichtenstein P, Bellocco R, et al. 2001. Increased risks of circulatory diseases in late pregnancy and puerperium. Epidemiology, 12:456-60.